MedTrace Logo

HFNO Reducing the Incidence of Hypoxia for Hysteroscopy Sedated With Propofol

NCT05049395 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 960

Last updated 2021-10-01

No results posted yet for this study

Summary

To determine whether high-flow nasal cannula oxygen can reduce the incidence of hypoxia during the procedure of sedated hysteroscopy.

Conditions

  • Endometritis
  • Tuberculous Endometritis
  • Subseptate Uterus
  • Endometrial Polyps

Interventions

DEVICE

High Flow Nasal Cannula oxygen (HFNO)

The AIRVO2 is set at 30L/min, FiO2 100%, and 37℃ before anesthesia induction，and then 60L/min until the end of the procedure of sedated hysteroscopy.

DEVICE

Regular oxygen

The patients are administered oxygen of 3L-6L/min until the end of the hysteroscopy operation.

Sponsors & Collaborators

  • RenJi Hospital

    lead OTHER

Principal Investigators

  • Su Diansan, PhD · Department of Anesthesiology

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-09-30
Primary Completion
2022-09-30
Completion
2022-09-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05049395 on ClinicalTrials.gov